Trametes versicolor (Turkey Tail Mushrooms) and the Treatment of Breast Cancer.
作者信息
Stamets Paul
机构信息
Paul Stamets is the owner and director of research at Fungi Perfecti Laboratories, Kamilche Point, Washington, United States.
出版信息
Glob Adv Health Med. 2012 Nov;1(5):20. doi: 10.7453/gahmj.2012.1.5.007. Epub 2012 Nov 1.
Abstract
摘要
相似文献
1
Trametes versicolor (Turkey Tail Mushrooms) and the Treatment of Breast Cancer.
Glob Adv Health Med. 2012 Nov;1(5):20. doi: 10.7453/gahmj.2012.1.5.007. Epub 2012 Nov 1.
2
Mycochemical Investigation of the Turkey Tail Medicinal Mushroom Trametes versicolor (Higher Basidiomycetes): A Potential Application of the Isolated Compounds in Documented Pharmacological Studies.
Int J Med Mushrooms. 2015;17(3):255-65. doi: 10.1615/intjmedmushrooms.v17.i3.50.
3
Trametes versicolor: a possible tool for aflatoxin control.云芝：一种控制黄曲霉毒素的可能工具。
Int J Food Microbiol. 2006 Apr 1;107(3):243-9. doi: 10.1016/j.ijfoodmicro.2005.10.003. Epub 2005 Dec 6.
4
Species delimitation in Trametes: a comparison of ITS, RPB1, RPB2 and TEF1 gene phylogenies.担子菌属种的划分：ITS、RPB1、RPB2 和 TEF1 基因系统发育的比较。
Mycologia. 2014 Jul-Aug;106(4):735-45. doi: 10.3852/13-275. Epub 2014 Jun 4.
5
Effects of polysaccharopeptide from Trametes versicolor and amoxicillin on the gut microbiome of healthy volunteers: a randomized clinical trial.云芝多糖和阿莫西林对健康志愿者肠道微生物组的影响：一项随机临床试验。
Gut Microbes. 2014 Jul 1;5(4):458-67. doi: 10.4161/gmic.29558. Epub 2014 Jul 9.
6
28-day oral safety evaluation of extracellular polysaccharopeptides produced in submerged culture from the turkey tail medicinal mushroom Trametes versicolor (L.:Fr.) Pilát LH-1 in mice.对云芝Trametes versicolor (L.:Fr.) Pilát LH-1深层培养产生的细胞外多糖肽在小鼠体内进行28天的口服安全性评价。
Int J Med Mushrooms. 2011;13(3):227-36. doi: 10.1615/intjmedmushr.v13.i3.20.
7
Tramesan, a novel polysaccharide from Trametes versicolor. Structural characterization and biological effects.云芝聚糖，一种来自云芝的新型多糖。结构表征及生物学效应。
PLoS One. 2017 Aug 22;12(8):e0171412. doi: 10.1371/journal.pone.0171412. eCollection 2017.
8
Control of oral human papillomavirus (HPV) by medicinal mushrooms, Trametes versicolor and Ganoderma lucidum: a preliminary clinical trial.云芝和灵芝对口腔人乳头瘤病毒（HPV）的控制：一项初步临床试验
Int J Med Mushrooms. 2014;16(5):497-8. doi: 10.1615/intjmedmushrooms.v16.i5.80.
9
Immune Modulation From Five Major Mushrooms: Application to Integrative Oncology.来自五种主要蘑菇的免疫调节作用：在整合肿瘤学中的应用
Integr Med (Encinitas). 2014 Feb;13(1):32-44.
10
Simultaneous production of laccase and degradation of bisphenol A with Trametes versicolor cultivated on agricultural wastes.利用农业废弃物培养云芝同时产漆酶及降解双酚A
Bioprocess Biosyst Eng. 2017 Aug;40(8):1237-1245. doi: 10.1007/s00449-017-1783-1. Epub 2017 May 23.
引用本文的文献
1
The mycelium of the Trametes versicolor synn. Coriolus versicolor (Turkey tail mushroom) exhibit anti-melanoma activity in vitro.云芝的菌丝体（彩色珊瑚菌）在体外显示出抗黑色素瘤活性。
Biomed Pharmacother. 2023 May;161:114424. doi: 10.1016/j.biopha.2023.114424. Epub 2023 Feb 22.
2
Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy.药用蘑菇作为未来癌症治疗中天然化合物的一个有吸引力的新来源。
Oncotarget. 2018 Jun 26;9(49):29259-29274. doi: 10.18632/oncotarget.25660.
本文引用的文献
1
Phase 1 Clinical Trial of Trametes versicolor in Women with Breast Cancer.云芝对乳腺癌女性的1期临床试验。
ISRN Oncol. 2012;2012:251632. doi: 10.5402/2012/251632. Epub 2012 May 30.
2
Medicinal mushroom modulators of molecular targets as cancer therapeutics.作为癌症治疗药物的药用蘑菇分子靶点调节剂。
Appl Microbiol Biotechnol. 2005 Jun;67(4):453-68. doi: 10.1007/s00253-004-1787-z. Epub 2005 Feb 23.
3
Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the Nishinihon Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) of Japan.日本西日本乳腺癌辅助化学内分泌治疗合作研究组（ACETBC）开展的II期乳腺癌患者术后辅助随机试验：比较化学内分泌治疗、化疗和免疫治疗的5年结果。
Eur J Cancer. 1996 Feb;32A(2):235-42. doi: 10.1016/0959-8049(95)00579-x.
Zotero 插件